Outcome measures | BF Group (n = 20 patients) mean ± SD | PTNS Group (n = 20 patients) mean ± SD | Combined Group (n = 20 patients) mean ± SD | Test of significance | P |
---|---|---|---|---|---|
Primary outcome measure | Â | Â | Â | Â | Â |
 Wexner Faecal Continence scale |  |  |  |  |  |
  Initial assessment | 10.80 ± 1.962 | 10.00 ± 1.71 | 10.00 ± 1.52 | K = 2.201 | 0.333 |
  Follow-up assessment | 6.80 ± 2.83 | 7.85 ± 2.62 | 5.15 ± 1.72 | K = 10.572 | 0.005* |
 Test of significance | Z =  − 3.933 | Z =  − 3.658 | Z =  − 3.980 |  |  |
  P†|  ≤ 0.0001* |  ≤ 0.0001* |  ≤ 0.0001* |  |  |
  P‡ | P1 = 0.196 | P2 = 0.001* | P3 = 0.065 |  |  |
Secondary outcome measures | Â | Â | Â | Â | Â |
 Maximal squeezing anal pressure (hPa) |  |  |  |  |  |
  Initial assessment | 58.95 ± 16.55 | 60.55 ± 17.36 | 56.90 ± 20.40 | K = 0.368 | 0.832 |
  Follow-up assessment | 78.75 ± 26.17 | 64.40 ± 16.78 | 80.75 ± 25.62 | K = 4.748 | 0.093 |
 Test of significance | Z =  − 3.921 | Z =  − 3.931 | Z =  − 3.922 |  |  |
  P†|  ≤ 0.0001* |  ≤ 0.0001* |  ≤ 0.0001* |  |  |
  P‡ | P1 = 0.088 | P2 = 0.046* | P3 = 0.645 |  |  |
 Maximal voluntary anal contraction time (seconds) |  |  |  |  |  |
  Initial assessment | 4.20 ± 1.79 | 4.30 ± 1.94 | 4.45 ± 1.98 | K = 0.133 | 0.936 |
  Follow-up assessment | 6.50 ± 2.50 | 5.65 ± 2.20 | 7.65 ± 2.32 | K = 6.963 | 0.031* |
 Test of significance | Z =  − 3.872 | Z =  − 3.834 | Z =  − 3.958 |  |  |
  P†|  ≤ 0.0001* |  ≤ 0.0001* |  ≤ 0.0001* |  |  |
  P‡ | P1 = 0.289 | P2 = 0.006* | P3 = 0.183 |  |  |
 Patient global assessment of effect of FI on quality of life |  |  |  |  |  |
  Initial assessment | 6.45 ± 1.70 | 6.60 ± 1.75 | 6.50 ± 1.46 | K = 0.080 | 0.961 |
  Follow-up assessment | 3.90 ± 2.14 | 5.45 ± 2.28 | 3.10 ± 1.33 | K = 11.602 | 0.003* |
 Test of significance | Z =  − 3.949 | Z =  − 2.842 | Z =  − 4.018 |  |  |
  P†|  ≤ 0.0001* |  ≤ 0.0001* |  ≤ 0.0001* |  |  |
  P‡ | P1 = 0.027* | P2 ≤ 0.0001* | P3 = 0.278 |  |  |